Sex- related differences in the factors associated with outcomes among patients with strokes of undetermined source: a hospital-based follow-up study

References

• GBD. 2017 disease and injury incidence and prevalence collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–1858.
   PubMed Web of Science ®Google Scholar
• Johnson CO, Nguyen M, Roth GA, GBD. 2016 stroke collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):439–458.
   PubMed Web of Science ®Google Scholar
• Ning X, Sun J, Jiang R, et al. Increased stroke burdens among the low-income young and middle aged in rural China. Stroke. 2017;48(1):77–83.
   PubMed Web of Science ®Google Scholar
• Zhu D, Shi X, Nicholas S, et al. Medical service utilization and direct medical cost of stroke in urban China. Int J Health Policy Manag. 2020. DOI:10.34172/ijhpm.2020.111
   PubMedGoogle Scholar
• Cha YJ. The economic burden of stroke based on South Korea’s national health insurance claims database. Int J Health Policy Manag. 2018;7(10):904–909.
   PubMed Web of Science ®Google Scholar
• Luengo-Fernandez R, Violato M, Candio P, et al. Economic burden of stroke across Europe: A population-based cost analysis. Eur Stroke J. 2020;5(1):17–25.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41.
   PubMed Web of Science ®Google Scholar
• Rücker V, Heuschmann PU, O’Flaherty M, et al. Twenty-year time trends in long-term case-fatality and recurrence rates after ischemic stroke stratified by etiology. Stroke. 2020;51(9):2778–2785.
   PubMed Web of Science ®Google Scholar
• Baye M, Hintze A, Gordon-Murer C, et al. Stroke characteristics and outcomes of adult patients in Northwest Ethiopia. Front Neurol. 2020;11:428.
   PubMed Web of Science ®Google Scholar
• Tsai CF, Thomas B, Sudlow CL. Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. Neurology. 2013;81(3):264–272.
   PubMed Web of Science ®Google Scholar
• Martinez-Majander N, Aarnio K, Pirinen J, et al. Embolic strokes of undetermined source in young adults: baseline characteristics and long-term outcome. Eur J Neurol. 2018;25(3):535–541.
   PubMed Web of Science ®Google Scholar
• Perera KS, Vanassche T, Bosch J, et al. Embolic strokes of undetermined source: prevalence and patient features in the ESUS Global Registry. Int J Stroke. 2016;11(5):526–533.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Bernstein RA, Passman R, et al. Cryptogenic Stroke: research and Practice. Circ Res. 2017;120(3):527–540.
   PubMed Web of Science ®Google Scholar
• Li L, Yiin GS, Geraghty OC, et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol. 2015;14(9):903–913.
   PubMed Web of Science ®Google Scholar
• Phan HT, Blizzard CL, Reeves MJ, et al. Sex differences in long-term mortality after stroke in the INSTRUCT (INternational STRoke oUtComes sTudy): a meta-analysis of individual participant data. Circ Cardiovasc Qual Outcomes. 2017;10(2). DOI:10.1161/CIRCOUTCOMES.116.003436
   PubMed Web of Science ®Google Scholar
• Berglund A, Schenck-Gustafsson K, von Euler M. Sex differences in the presentation of stroke. Maturitas. 2017;99:47–50.
   PubMed Web of Science ®Google Scholar
• Carcel C, Wang X, Sandset EC, et al. Sex differences in treatment and outcome after stroke: pooled analysis including 19,000 participants. Neurology. 2019;93(24):e2170–e2180.
   PubMed Web of Science ®Google Scholar
• Lewsey JD, Gillies M, Jhund PS, et al. Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke. 2009;40(4):1038–1043.
   PubMed Web of Science ®Google Scholar
• Hwong WY, Bots ML, Selvarajah S, et al. Sex differences in stroke metrics among Southeast Asian countries: results from the global burden of disease study 2015. Int J Stroke. 2019;14(8):826–834.
   PubMed Web of Science ®Google Scholar
• Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40(4):1082–1090.
   PubMed Web of Science ®Google Scholar
• Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337(8756):1521–1526.
   PubMed Web of Science ®Google Scholar
• Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH stroke scale using video training. NINDS TPA stroke study group. Stroke. 1994;25(11):2220–2226.
   PubMed Web of Science ®Google Scholar
• van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–607.
   PubMed Web of Science ®Google Scholar
• Skolnik N. Treating hypercholesterolemia in older adults-reply. JAMA. 2019;322(7):695–696.
   PubMed Web of Science ®Google Scholar
• Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases–report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15(3):245–252.
   PubMed Web of Science ®Google Scholar
• Leventis I, Perlepe K, Sagris D, et al. Characteristics and outcomes of embolic stroke of undetermined source according to stroke severity. Int J Stroke. 2020;15(8):866–871.
   PubMed Web of Science ®Google Scholar
• Liu X, Li T, Diao S, et al. The global burden of cerebral small vessel disease related to neurological deficit severity and clinical outcomes of acute ischemic stroke after IV rt-PA treatment. Neurol Sci. 2019;40(6):1157–1166.
   PubMed Web of Science ®Google Scholar
• Rost NS, Bottle A, Lee JM, et al. Stroke severity is a crucial predictor of outcome: an international prospective validation study. J Am Heart Assoc. 2016;5(1). DOI:10.1161/JAHA.115.002433
   PubMed Web of Science ®Google Scholar
• Soh J, Iqbal J, Queiroz J, et al. MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med. 2013;19(7):892–900.
   PubMed Web of Science ®Google Scholar
• Won KB, Park GM, Yang YJ, et al. Independent role of low-density lipoprotein cholesterol in subclinical coronary atherosclerosis in the absence of traditional cardiovascular risk factors. Eur Heart J Cardiovasc Imaging. 2019;20(8):866–872.
   PubMed Web of Science ®Google Scholar
• Staudt A, Stock K, Gande N, et al. Impact of lifestyle and cardiovascular risk factors on early atherosclerosis in a large cohort of healthy adolescents: the Early Vascular Ageing (EVA)-tyrol study. Atherosclerosis. 2020;305:26–33.
   PubMed Web of Science ®Google Scholar
• Ji X, Leng XY, Dong Y, et al. Modifiable risk factors for carotid atherosclerosis: a meta-analysis and systematic review. Ann Transl Med. 2019;7(22):632.
   PubMed Web of Science ®Google Scholar
• Aronow WS. Managing hyperlipidaemia in the elderly: special considerations for a population at high risk. Drugs Aging. 2006;23(3):181–189.
   PubMed Web of Science ®Google Scholar
• O’Brien EC, Greiner MA, Xian Y, et al. Clinical effectiveness of statin therapy after ischemic stroke: primary results from the statin therapeutic area of the patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study. Circulation. 2015;132(15):1404–1413.
   PubMed Web of Science ®Google Scholar
• Larry BG, Tsivgoulis G, Katsanos AH, et al. Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke. Neurology. 2016;87(7):746.
   PubMed Web of Science ®Google Scholar
• Flint AC, Conell C, Klingman JG, et al. Impact of increased early statin administration on ischemic stroke outcomes: a multicenter electronic medical record intervention. J Am Heart Assoc. 2016;5(8). DOI:10.1161/JAHA.116.003413
   PubMed Web of Science ®Google Scholar
• Choi KH, Seo WK, Park MS, et al. Effect of statin therapy on outcomes of patients with acute ischemic stroke and atrial fibrillation. J Am Heart Assoc. 2019;8(24):e013941.
   PubMed Web of Science ®Google Scholar
• Stroke prevetion by aggressive reduction in cholestrol levels (SPARCL) Investigators; Karam JG, Loney-Hutchinson L, McFarlane SI. High-dose atorvastatin after stroke or transient ischemic attack: the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) investigators. J Cardiometab Syndr. 2008;3(1):68–69.
   PubMedGoogle Scholar
• Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–2486.
   PubMed Web of Science ®Google Scholar
• Kamel H, Longstreth WT Jr, Tirschwell DL, et al. The AtRial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods. Int J Stroke. 2019;14(2):207–214.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Chang AD, Ricci BA, et al. Early elevated troponin levels after ischemic stroke suggests a cardioembolic source. Stroke. 2018;49(1):121–126.
   PubMed Web of Science ®Google Scholar
• Ahmad Y, Howard JP, Arnold A, et al. Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials. Eur Heart J. 2018;39(18):1638–1649.
   PubMed Web of Science ®Google Scholar
• Kasner SE, Swaminathan B, Lavados P, et al. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurol. 2018;17(12):1053–1060.
   PubMed Web of Science ®Google Scholar
• Navi BB, Singer S, Merkler AE, et al. Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology. 2014;83(1):26–33.
   PubMed Web of Science ®Google Scholar
• Coutinho JM, Derkatch S, Potvin AR, et al. Nonstenotic carotid plaque on CT angiography in patients with cryptogenic stroke. Neurology. 2016;87(7):665–672.
   PubMed Web of Science ®Google Scholar
• Gupta A, Gialdini G, Giambrone AE, et al. Association Between Nonstenosing Carotid Artery Plaque on MR Angiography and Acute Ischemic Stroke. JACC Cardiovasc Imaging. 2016;9(10):1228–1229.
   PubMed Web of Science ®Google Scholar
• Triantafyllou S, Katsanos AH, Dilaveris P, et al. Implantable cardiac monitoring in the secondary prevention of cryptogenic stroke. Ann Neurol. 2020;88(5):946–955.
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Katsanos AH, Grory BM, et al. Prolonged cardiac rhythm monitoring and secondary stroke prevention in patients with cryptogenic cerebral ischemia. Stroke. 2019;50(8):2175–2180.
   PubMed Web of Science ®Google Scholar
• Fukutomi M, Wilkins B, Søndergaard L. The role of device closure of patent foramen ovale in patients with cryptogenic stroke. J Intern Med. 2020;288(4):400–409.
   PubMed Web of Science ®Google Scholar
• Ntaios G, Papavasileiou V, Milionis H, et al. Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis. Stroke. 2015;46(1):176–181.
   PubMed Web of Science ®Google Scholar
• Nahab F, Sharashidze V, Liu M, et al. Markers of coagulation and hemostatic activation aid in identifying causes of cryptogenic stroke. Neurology. 2020;94(18):e1892–e1899.
   PubMed Web of Science ®Google Scholar
• Fakih R, Roa JA, Bathla G, et al. Detection and quantification of symptomatic atherosclerotic plaques with high-resolution imaging in cryptogenic stroke. Stroke. 2020;51:STROKEAHA120031167.
   Web of Science ®Google Scholar
• Palà E, Pagola J, Juega J, et al. BNP over NT-proBNP to predict incident atrial fibrillation after cryptogenic stroke. Eur J Neurol. 2021;28(2):540-547. doi: 10.1111/ene.14579.
   Google Scholar